At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Uncontrolled Lower Respiratory Symptoms in the World Trade Center Survivor Program
In Brief
A clinical study evaluating Fluticasone propionate 230mcg for 3 Months, Current Treatment or no treatment, and 1 other intervention for Lung Diseases and Medication Compliance. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The purpose of this study is to understand why patients in the World Trade Center program have continuing breathing problems. This study will improve investigators understanding of breathing problems among individuals with World Trade Center exposure by allowing them to review and monitor medication use, lung function, and examine other conditions that can contribute to problems with breathing. The findings from the study will help investigators understand why some people have persistent lower respiratory symptoms (breathing problems) after their exposure to World Trade Center dust and fumes, and may help guide better management and treatment of these symptoms.
Study Details
Timeline
Interventions
Patients who had symptoms at monitoring visit but are now controlled at V1 will be asked to continue their current treatment (or no treatment) and will continue with the study. They will not be provided with any medications.